scope:

This Directive:

Applies to the Office of the Secretary of Defense, the Military Departments, the Chairman of the Joint Chiefs of Staff, the Combatant Commands, the Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD Field Activities and all other organizational entities within the Department of Defense (hereafter referred to collectively as "the DoD Components").

Applies to all uses of investigational new drugs by the Department of Defense for force health protection.

Does not apply to actions by DoD healthcare providers that are within standard medical practice in the United States and are not subject to FDA regulations at reference (c).

(e) DoD Directive 1404.10, "Emergency-Essential (E-E) DoD U.S. Citizen Civilian Employees," April 10, 1992

(f) DoD Instruction 3020.37, "Continuation of Essential DoD Contractor Services During Crises," November 6, 1990